Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 19/20 | 0.65 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.43 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.43 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.43 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6173985 | 0.90 | ECE1 (0.64) | ECE1 | |
| SCHEMBL6174890 | 0.90 | ECE1 (0.72) | ECE1 | |
| SCHEMBL6019258 | 0.86 | ECE1 (0.75) | ECE1 | |
| SCHEMBL6610640 | 0.85 | ECE1 (0.75) | ECE1KCNQ3KCNQ2KCNQ4KCNQ5 | |
| SCHEMBL6018597 | 0.81 | ECE1 (0.84) | ECE1 | |
| SCHEMBL8361099 | 0.79 | ECE1 (1.00) | ECE1 | |
| SCHEMBL6175629 | 0.79 | ECE1 (0.71) | ECE1 | |
| SCHEMBL6173723 | 0.78 | ECE1 (0.62) | ECE1KCNQ3KCNQ2KCNQ4KCNQ5 | |
| SCHEMBL8337380 | 0.77 | ECE1 (0.84) | ECE1 | |
| SCHEMBL6175488 | 0.77 | ECE1 (0.73) | ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1432415-B1 | SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2005-12-28 | — | — | EP | disclosed |
| EP-1432415-A1 | SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Bayer HealthCare AG (DE) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003028719-A1 | SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2003-04-10 | — | — | WO | disclosed |